Finding. Apoptosis is supposed to hide the mitochondrial genome. The outer membrane opens, cytochrome c leaves, caspases fire, and the cyclic GMP-AMP synthase / stimulator of interferon genes (cGAS/STING) pathway is supposed to stay dark. When caspases are weak, mitochondrial DNA still reaches the cytosol and the cell becomes an inflammatory object. Hohorst, Garcia-Saez and colleagues name the inner-membrane hole: the active N-terminal fragment of Gasdermin E (GSDME-N) damages mitochondria before the plasma membrane fails.
They see GSDME-N pore-like nano-assemblies in the mitochondrial inner membrane of apoptotic cells and of isolated mitochondria. They match those assemblies to a cryo-electron microscopy structure of the GSDME-N pore in mitochondria-like membranes. The anchor domain inserts deeply and sets a cardiolipin binding preference, which is the lipid that marks mitochondrial membranes. When Gasdermin E is removed, cristae swell less, the inner membrane extrudes less, and less mitochondrial DNA leaves. STING activation and inflammatory responses fall if caspases are also blocked.
Why this paper matters
The field has a clean outer-membrane story (BAX/BAK) and a messy inner-membrane story. Herniation, lipid peroxidation, and mitochondrial-derived vesicles have all been nominated. A gasdermin pore with a structure and a cardiolipin preference is a different class of claim: a protein you can delete, a lipid you can titrate, an assembly you can image.
It also recuts Gasdermin E. The textbook version punches the plasma membrane and kills the cell. Here the same fragment hits mitochondria first. That order matters for anyone who uses caspase inhibitors, gasdermin-E-positive tumors, or delayed-clearance apoptosis and then wonders why STING lights up.
Cardiolipin is not a decorative lipid code. If the anchor domain is the cardiolipin reader, then inner-membrane composition becomes a gate on whether apoptotic mitochondria leak genome.
What they actually measured
Three linked observations sit in the abstract. First, timing: GSDME-N damages mitochondria before plasma-membrane disruption. Second, structure: pore-like nano-assemblies on inner membranes, bridged to a cryo-electron microscopy pore in mitochondria-like bilayers, with deep anchor insertion and cardiolipin preference. Third, genetics: Gasdermin E loss reduces cristae swelling, inner-membrane extrusion, and mitochondrial DNA release, and then reduces STING and inflammation under caspase inhibition.
Keep the scope honest. The abstract does not give a pore diameter, a lipid mole fraction, or a residual mitochondrial DNA leak after Gasdermin E loss. It does not retire BAX/BAK or vesicle routes. It does say the inflammatory phenotype is the caspase-low condition, which is the clinically interesting one.
How to read the score
Low nineties. Inner-membrane permeabilization plus mitochondrial DNA plus a structure is the weekly mechanism paper. Confidence is high for the direction of the Gasdermin E claim as stated, not for exclusivity or for a human inflammatory disease.
What to do with it
If you model apoptotic mitochondrial DNA release, add GSDME-N to the inner membrane and condition STING on caspase activity. Pull the cryo-electron microscopy pore, the cardiolipin-binding experiment, and the depletion panels for cristae, extrusion, mitochondrial DNA, and STING. Do not write that Gasdermin E is the only inner-membrane pore from this brief.